Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-08-24

AUTHORS

Frédérique Maire, Yann Le Baleur, Vinciane Rebours, Marie Pierre Vullierme, Anne Couvelard, Hélène Voitot, Alain Sauvanet, Olivia Hentic, Philippe Lévy, Philippe Ruszniewski, Pascal Hammel

ABSTRACT

OBJECTIVES: Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search for predictive factors of relapse and pancreatic insufficiency, and to compare patients with type 1 and type 2 AIP. METHODS: All consecutive patients followed up for AIP in our center between 1999 and 2008 were included. Two groups were defined: (a) patients with type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria; (b) patients with definitive/probable type 2 AIP including those with histologically confirmed idiopathic duct-centric pancreatitis ("definitive") or suggestive imaging, normal serum IgG4, and response to steroids ("probable"). AIP-related events and pancreatic exocrine/endocrine insufficiency were looked for during follow-up. Predictive factors of relapse and pancreatic insufficiency were analyzed. RESULTS: A total of 44 patients (22 males), median age 37.5 (19-73) years, were included: 28 patients (64%) with type 1 AIP and 16 patients (36%) with type 2 AIP. First-line treatment consisted of steroids or pancreatic resection in 59 and 27% of the patients, respectively. Median follow-up was 41 (5-130) months. Steroids were effective in all treated patients. Relapse was observed in 12 patients (27%), after a median delay of 6 months (1-70). Four patients received azathioprine because of steroid resistance/dependence. High serum IgG4 level, pain at time of diagnosis, and other organ involvement were associated with relapse (P<0.05). At the end point, pancreatic atrophy was observed in 35% of patients. Exocrine and endocrine insufficiencies were present in 34 and 39% of the patients, respectively. At univariate analysis, no factor was associated with exocrine insufficiency, although female gender (P=0.04), increasing age (P=0.006), and type 1 AIP (P=0.001) were associated with the occurrence of diabetes. Steroid/azathioprine treatment did not prevent pancreatic insufficiency. Type 2 AIP was more frequently associated with inflammatory bowel disease than type 1 AIP (31 and 3%, respectively), but relapse rates were similar in both groups. CONCLUSIONS: Relapse occurs in 27% of AIP patients and is more frequent in patients with high serum IgG4 levels at the time of diagnosis. Pancreatic atrophy and functional insufficiency occur in more than one-third of the patients within 3 years of diagnosis. The outcome of patients with type 2 AIP, a condition often associated with inflammatory bowel disease, is not different from that of patients with type 1 AIP, except for diabetes. More... »

PAGES

151

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/ajg.2010.314

DOI

http://dx.doi.org/10.1038/ajg.2010.314

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032980160

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20736934


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoimmune Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy, Needle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exocrine Pancreatic Insufficiency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Ducts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maire", 
        "givenName": "Fr\u00e9d\u00e9rique", 
        "id": "sg:person.01351504544.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351504544.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Baleur", 
        "givenName": "Yann", 
        "id": "sg:person.01114775766.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114775766.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rebours", 
        "givenName": "Vinciane", 
        "id": "sg:person.01017252245.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017252245.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Radiology, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vullierme", 
        "givenName": "Marie Pierre", 
        "id": "sg:person.01231224366.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231224366.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Pathology, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Couvelard", 
        "givenName": "Anne", 
        "id": "sg:person.0751137045.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751137045.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biology, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Biology, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voitot", 
        "givenName": "H\u00e9l\u00e8ne", 
        "id": "sg:person.01310130627.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310130627.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Beaujon Hospital, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Surgery, Beaujon Hospital, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sauvanet", 
        "givenName": "Alain", 
        "id": "sg:person.01201614045.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201614045.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hentic", 
        "givenName": "Olivia", 
        "id": "sg:person.0736275266.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736275266.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00e9vy", 
        "givenName": "Philippe", 
        "id": "sg:person.0740232450.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740232450.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruszniewski", 
        "givenName": "Philippe", 
        "id": "sg:person.0640551545.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640551545.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hammel", 
        "givenName": "Pascal", 
        "id": "sg:person.01355345644.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355345644.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1111/j.1572-0241.2008.01959_1.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010128041", 
          "https://doi.org/10.1111/j.1572-0241.2008.01959_1.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00296-009-0843-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017767428", 
          "https://doi.org/10.1007/s00296-009-0843-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2009.327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039698368", 
          "https://doi.org/10.1038/ajg.2009.327"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2005.00270.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017381662", 
          "https://doi.org/10.1111/j.1572-0241.2005.00270.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2009.325", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006114762", 
          "https://doi.org/10.1038/ajg.2009.325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-003-1178-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005542799", 
          "https://doi.org/10.1007/s00535-003-1178-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2009.336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036700394", 
          "https://doi.org/10.1038/ajg.2009.336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2007.01531.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027749897", 
          "https://doi.org/10.1111/j.1572-0241.2007.01531.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-002-1108-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075314630", 
          "https://doi.org/10.1007/s00535-002-1108-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-08-24", 
    "datePublishedReg": "2010-08-24", 
    "description": "OBJECTIVES: Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search for predictive factors of relapse and pancreatic insufficiency, and to compare patients with type 1 and type 2 AIP.\nMETHODS: All consecutive patients followed up for AIP in our center between 1999 and 2008 were included. Two groups were defined: (a) patients with type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria; (b) patients with definitive/probable type 2 AIP including those with histologically confirmed idiopathic duct-centric pancreatitis (\"definitive\") or suggestive imaging, normal serum IgG4, and response to steroids (\"probable\"). AIP-related events and pancreatic exocrine/endocrine insufficiency were looked for during follow-up. Predictive factors of relapse and pancreatic insufficiency were analyzed.\nRESULTS: A total of 44 patients (22 males), median age 37.5 (19-73) years, were included: 28 patients (64%) with type 1 AIP and 16 patients (36%) with type 2 AIP. First-line treatment consisted of steroids or pancreatic resection in 59 and 27% of the patients, respectively. Median follow-up was 41 (5-130) months. Steroids were effective in all treated patients. Relapse was observed in 12 patients (27%), after a median delay of 6 months (1-70). Four patients received azathioprine because of steroid resistance/dependence. High serum IgG4 level, pain at time of diagnosis, and other organ involvement were associated with relapse (P<0.05). At the end point, pancreatic atrophy was observed in 35% of patients. Exocrine and endocrine insufficiencies were present in 34 and 39% of the patients, respectively. At univariate analysis, no factor was associated with exocrine insufficiency, although female gender (P=0.04), increasing age (P=0.006), and type 1 AIP (P=0.001) were associated with the occurrence of diabetes. Steroid/azathioprine treatment did not prevent pancreatic insufficiency. Type 2 AIP was more frequently associated with inflammatory bowel disease than type 1 AIP (31 and 3%, respectively), but relapse rates were similar in both groups.\nCONCLUSIONS: Relapse occurs in 27% of AIP patients and is more frequent in patients with high serum IgG4 levels at the time of diagnosis. Pancreatic atrophy and functional insufficiency occur in more than one-third of the patients within 3 years of diagnosis. The outcome of patients with type 2 AIP, a condition often associated with inflammatory bowel disease, is not different from that of patients with type 1 AIP, except for diabetes.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/ajg.2010.314", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1019809", 
        "issn": [
          "0002-9270", 
          "1572-0241"
        ], 
        "name": "The American Journal of Gastroenterology", 
        "publisher": "Wolters Kluwer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "106"
      }
    ], 
    "keywords": [
      "type 2 autoimmune pancreatitis", 
      "type 1 autoimmune pancreatitis", 
      "high serum IgG4 levels", 
      "serum IgG4 levels", 
      "outcome of patients", 
      "autoimmune pancreatitis", 
      "time of diagnosis", 
      "inflammatory bowel disease", 
      "pancreatic insufficiency", 
      "endocrine insufficiency", 
      "IgG4 levels", 
      "bowel disease", 
      "predictive factors", 
      "pancreatic atrophy", 
      "probable type 2 AIP", 
      "exocrine/endocrine insufficiency", 
      "first-line treatment", 
      "type 1", 
      "long-term outcomes", 
      "idiopathic duct-centric pancreatitis", 
      "normal serum IgG4", 
      "age 37.5 years", 
      "year of diagnosis", 
      "occurrence of diabetes", 
      "HISORt criteria", 
      "suggestive imaging", 
      "azathioprine treatment", 
      "serum IgG4", 
      "pancreatic resection", 
      "organ involvement", 
      "relapse rate", 
      "consecutive patients", 
      "exocrine insufficiency", 
      "exocrine function", 
      "median delay", 
      "AIP patients", 
      "univariate analysis", 
      "female gender", 
      "pancreatic endocrine", 
      "relapse", 
      "patients", 
      "insufficiency", 
      "functional insufficiency", 
      "one-third", 
      "end point", 
      "pancreatitis", 
      "diagnosis", 
      "steroids", 
      "diabetes", 
      "atrophy", 
      "outcomes", 
      "international consensus", 
      "treatment", 
      "disease", 
      "months", 
      "azathioprine", 
      "resection", 
      "pain", 
      "group", 
      "IgG4", 
      "years", 
      "factors", 
      "exocrine", 
      "endocrine", 
      "age", 
      "levels", 
      "total", 
      "involvement", 
      "imaging", 
      "gender", 
      "aim", 
      "response", 
      "criteria", 
      "consensus", 
      "center", 
      "time", 
      "occurrence", 
      "rate", 
      "events", 
      "function", 
      "delay", 
      "focus", 
      "analysis", 
      "definition", 
      "conditions", 
      "point", 
      "dependence", 
      "type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria", 
      "AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria", 
      "meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria", 
      "duct-centric pancreatitis", 
      "pancreatic exocrine/endocrine insufficiency", 
      "median age 37.5 (19-73) years", 
      "steroid resistance/dependence", 
      "resistance/dependence", 
      "Steroid/azathioprine treatment"
    ], 
    "name": "Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis", 
    "pagination": "151", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032980160"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/ajg.2010.314"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20736934"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/ajg.2010.314", 
      "https://app.dimensions.ai/details/publication/pub.1032980160"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_506.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/ajg.2010.314"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ajg.2010.314'


 

This table displays all metadata directly associated to this object as RDF triples.

376 TRIPLES      22 PREDICATES      157 URIs      140 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/ajg.2010.314 schema:about N04d7b96ee9e84df0ba077b1543e8285d
2 N07a6be823acd4a23bc070b762b0a7917
3 N1eb15bb53e1b41d5907e71288b941f52
4 N26c75aa9d2f14618af71299ebba2fd68
5 N2d43e39a955a49dc8005d00199859ef0
6 N3b640b61783644d49dfb918214d3587d
7 N3dcb8c7a2e0743ca8e9c620adc591347
8 N55f1d8f55f364455b70fd8a8ce2b6426
9 N5bb8e229987148d0b8ffcd7d552fae9f
10 N60acd83642e64e6a89916c642ae8a53c
11 N60c7614f98164ea18c1a8692f273ebd2
12 N6bb87403e65f414f91a6e9731789def1
13 N70448ef956ac409f80098be531f1e5f7
14 N73e579a59c1d41c18b38cd7315b0627f
15 N85486809b6b3427e8bbad7befc9d7b74
16 N91109bcd3c374d768d0dda0cb76b2174
17 N9405f1dbe3e248a1bf10f0e750a3078b
18 N99d590c927ba477aa6127fff3d263b40
19 N9b27ce9a8a6f4d5e9d0a05a98e02e719
20 Nae4926d5137f4daba7cb24095244a526
21 Nbdd961d19d60424dbe879f2c0286c1d4
22 Nbe5bada30950421b99ac4cfd39dc3c81
23 Nbe5c6aea85354ebba25527aa0cc3f165
24 Nc81c0e3f859f426aa929209afda6fc73
25 Nec665f292d374fcd99785ef71f153930
26 Nf2e0a40120d446aca7d82c83e82bb7f9
27 anzsrc-for:11
28 anzsrc-for:1103
29 schema:author N2945e774a6a44e868f8079eb1380b245
30 schema:citation sg:pub.10.1007/s00296-009-0843-5
31 sg:pub.10.1007/s00535-002-1108-1
32 sg:pub.10.1007/s00535-003-1178-8
33 sg:pub.10.1038/ajg.2009.325
34 sg:pub.10.1038/ajg.2009.327
35 sg:pub.10.1038/ajg.2009.336
36 sg:pub.10.1111/j.1572-0241.2005.00270.x
37 sg:pub.10.1111/j.1572-0241.2007.01531.x
38 sg:pub.10.1111/j.1572-0241.2008.01959_1.x
39 schema:datePublished 2010-08-24
40 schema:datePublishedReg 2010-08-24
41 schema:description OBJECTIVES: Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search for predictive factors of relapse and pancreatic insufficiency, and to compare patients with type 1 and type 2 AIP. METHODS: All consecutive patients followed up for AIP in our center between 1999 and 2008 were included. Two groups were defined: (a) patients with type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria; (b) patients with definitive/probable type 2 AIP including those with histologically confirmed idiopathic duct-centric pancreatitis ("definitive") or suggestive imaging, normal serum IgG4, and response to steroids ("probable"). AIP-related events and pancreatic exocrine/endocrine insufficiency were looked for during follow-up. Predictive factors of relapse and pancreatic insufficiency were analyzed. RESULTS: A total of 44 patients (22 males), median age 37.5 (19-73) years, were included: 28 patients (64%) with type 1 AIP and 16 patients (36%) with type 2 AIP. First-line treatment consisted of steroids or pancreatic resection in 59 and 27% of the patients, respectively. Median follow-up was 41 (5-130) months. Steroids were effective in all treated patients. Relapse was observed in 12 patients (27%), after a median delay of 6 months (1-70). Four patients received azathioprine because of steroid resistance/dependence. High serum IgG4 level, pain at time of diagnosis, and other organ involvement were associated with relapse (P<0.05). At the end point, pancreatic atrophy was observed in 35% of patients. Exocrine and endocrine insufficiencies were present in 34 and 39% of the patients, respectively. At univariate analysis, no factor was associated with exocrine insufficiency, although female gender (P=0.04), increasing age (P=0.006), and type 1 AIP (P=0.001) were associated with the occurrence of diabetes. Steroid/azathioprine treatment did not prevent pancreatic insufficiency. Type 2 AIP was more frequently associated with inflammatory bowel disease than type 1 AIP (31 and 3%, respectively), but relapse rates were similar in both groups. CONCLUSIONS: Relapse occurs in 27% of AIP patients and is more frequent in patients with high serum IgG4 levels at the time of diagnosis. Pancreatic atrophy and functional insufficiency occur in more than one-third of the patients within 3 years of diagnosis. The outcome of patients with type 2 AIP, a condition often associated with inflammatory bowel disease, is not different from that of patients with type 1 AIP, except for diabetes.
42 schema:genre article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N54eca347608944d49ec8769bca1fe880
46 Nd0ab7a7fb9164d6987392b08a9ed7da5
47 sg:journal.1019809
48 schema:keywords AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria
49 AIP patients
50 HISORt criteria
51 IgG4
52 IgG4 levels
53 Steroid/azathioprine treatment
54 age
55 age 37.5 years
56 aim
57 analysis
58 atrophy
59 autoimmune pancreatitis
60 azathioprine
61 azathioprine treatment
62 bowel disease
63 center
64 conditions
65 consecutive patients
66 consensus
67 criteria
68 definition
69 delay
70 dependence
71 diabetes
72 diagnosis
73 disease
74 duct-centric pancreatitis
75 end point
76 endocrine
77 endocrine insufficiency
78 events
79 exocrine
80 exocrine function
81 exocrine insufficiency
82 exocrine/endocrine insufficiency
83 factors
84 female gender
85 first-line treatment
86 focus
87 function
88 functional insufficiency
89 gender
90 group
91 high serum IgG4 levels
92 idiopathic duct-centric pancreatitis
93 imaging
94 inflammatory bowel disease
95 insufficiency
96 international consensus
97 involvement
98 levels
99 long-term outcomes
100 median age 37.5 (19-73) years
101 median delay
102 meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria
103 months
104 normal serum IgG4
105 occurrence
106 occurrence of diabetes
107 one-third
108 organ involvement
109 outcome of patients
110 outcomes
111 pain
112 pancreatic atrophy
113 pancreatic endocrine
114 pancreatic exocrine/endocrine insufficiency
115 pancreatic insufficiency
116 pancreatic resection
117 pancreatitis
118 patients
119 point
120 predictive factors
121 probable type 2 AIP
122 rate
123 relapse
124 relapse rate
125 resection
126 resistance/dependence
127 response
128 serum IgG4
129 serum IgG4 levels
130 steroid resistance/dependence
131 steroids
132 suggestive imaging
133 time
134 time of diagnosis
135 total
136 treatment
137 type 1
138 type 1 AIP meeting HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to steroids) criteria
139 type 1 autoimmune pancreatitis
140 type 2 autoimmune pancreatitis
141 univariate analysis
142 year of diagnosis
143 years
144 schema:name Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis
145 schema:pagination 151
146 schema:productId N6f2cd38646b14b62bc2bda230492e486
147 N7487dd702ea9493db0c3064a9bffa80f
148 Nf05a9cc59e75469ea8ede0db2e53ab8a
149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032980160
150 https://doi.org/10.1038/ajg.2010.314
151 schema:sdDatePublished 2022-01-01T18:22
152 schema:sdLicense https://scigraph.springernature.com/explorer/license/
153 schema:sdPublisher N338dd3e7abc74708a4235b26ce9fed9d
154 schema:url https://doi.org/10.1038/ajg.2010.314
155 sgo:license sg:explorer/license/
156 sgo:sdDataset articles
157 rdf:type schema:ScholarlyArticle
158 N04d7b96ee9e84df0ba077b1543e8285d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Pancreatic Function Tests
160 rdf:type schema:DefinedTerm
161 N07a6be823acd4a23bc070b762b0a7917 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Immunohistochemistry
163 rdf:type schema:DefinedTerm
164 N0c5e7323e229471f8d50a8a67a578400 rdf:first sg:person.0751137045.27
165 rdf:rest N23a2489d6176498b8efa38ad338d4838
166 N1eb15bb53e1b41d5907e71288b941f52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Adult
168 rdf:type schema:DefinedTerm
169 N23a2489d6176498b8efa38ad338d4838 rdf:first sg:person.01310130627.51
170 rdf:rest Nffc74d6404854b49bcd1b231b7d726db
171 N26c75aa9d2f14618af71299ebba2fd68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Male
173 rdf:type schema:DefinedTerm
174 N2945e774a6a44e868f8079eb1380b245 rdf:first sg:person.01351504544.65
175 rdf:rest N547710f778974fdf97597576faa482dd
176 N2d43e39a955a49dc8005d00199859ef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Aged
178 rdf:type schema:DefinedTerm
179 N338dd3e7abc74708a4235b26ce9fed9d schema:name Springer Nature - SN SciGraph project
180 rdf:type schema:Organization
181 N3b640b61783644d49dfb918214d3587d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Prednisolone
183 rdf:type schema:DefinedTerm
184 N3dcb8c7a2e0743ca8e9c620adc591347 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Biopsy, Needle
186 rdf:type schema:DefinedTerm
187 N4d329218df8142b68b14b1278d33bea2 rdf:first sg:person.0740232450.15
188 rdf:rest N779524e772c6446bb0efb6560366e70d
189 N547710f778974fdf97597576faa482dd rdf:first sg:person.01114775766.42
190 rdf:rest N8c9a6cfed0f14eb89810345c344d6c46
191 N54eca347608944d49ec8769bca1fe880 schema:volumeNumber 106
192 rdf:type schema:PublicationVolume
193 N55f1d8f55f364455b70fd8a8ce2b6426 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Severity of Illness Index
195 rdf:type schema:DefinedTerm
196 N5bb8e229987148d0b8ffcd7d552fae9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Exocrine Pancreatic Insufficiency
198 rdf:type schema:DefinedTerm
199 N60acd83642e64e6a89916c642ae8a53c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Autoimmune Diseases
201 rdf:type schema:DefinedTerm
202 N60c7614f98164ea18c1a8692f273ebd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Humans
204 rdf:type schema:DefinedTerm
205 N615447ee4ed94018b8654629f9619a33 rdf:first sg:person.0736275266.26
206 rdf:rest N4d329218df8142b68b14b1278d33bea2
207 N6bb87403e65f414f91a6e9731789def1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Cohort Studies
209 rdf:type schema:DefinedTerm
210 N6f2cd38646b14b62bc2bda230492e486 schema:name doi
211 schema:value 10.1038/ajg.2010.314
212 rdf:type schema:PropertyValue
213 N70448ef956ac409f80098be531f1e5f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Middle Aged
215 rdf:type schema:DefinedTerm
216 N73e579a59c1d41c18b38cd7315b0627f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Young Adult
218 rdf:type schema:DefinedTerm
219 N7487dd702ea9493db0c3064a9bffa80f schema:name dimensions_id
220 schema:value pub.1032980160
221 rdf:type schema:PropertyValue
222 N779524e772c6446bb0efb6560366e70d rdf:first sg:person.0640551545.21
223 rdf:rest N7f7fe9d478224a13be17495f02c04ec8
224 N7f7fe9d478224a13be17495f02c04ec8 rdf:first sg:person.01355345644.55
225 rdf:rest rdf:nil
226 N85486809b6b3427e8bbad7befc9d7b74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name Follow-Up Studies
228 rdf:type schema:DefinedTerm
229 N8c9a6cfed0f14eb89810345c344d6c46 rdf:first sg:person.01017252245.99
230 rdf:rest Na85eec3f2a4840b9a2e263e8a02e9503
231 N91109bcd3c374d768d0dda0cb76b2174 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
232 schema:name Combined Modality Therapy
233 rdf:type schema:DefinedTerm
234 N9405f1dbe3e248a1bf10f0e750a3078b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
235 schema:name Pancreatic Ducts
236 rdf:type schema:DefinedTerm
237 N99d590c927ba477aa6127fff3d263b40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
238 schema:name Pancreatitis
239 rdf:type schema:DefinedTerm
240 N9b27ce9a8a6f4d5e9d0a05a98e02e719 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
241 schema:name Female
242 rdf:type schema:DefinedTerm
243 Na85eec3f2a4840b9a2e263e8a02e9503 rdf:first sg:person.01231224366.16
244 rdf:rest N0c5e7323e229471f8d50a8a67a578400
245 Nae4926d5137f4daba7cb24095244a526 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
246 schema:name Pancreatectomy
247 rdf:type schema:DefinedTerm
248 Nbdd961d19d60424dbe879f2c0286c1d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
249 schema:name Risk Assessment
250 rdf:type schema:DefinedTerm
251 Nbe5bada30950421b99ac4cfd39dc3c81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
252 schema:name Recurrence
253 rdf:type schema:DefinedTerm
254 Nbe5c6aea85354ebba25527aa0cc3f165 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
255 schema:name Immunoglobulin G
256 rdf:type schema:DefinedTerm
257 Nc81c0e3f859f426aa929209afda6fc73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
258 schema:name Kaplan-Meier Estimate
259 rdf:type schema:DefinedTerm
260 Nd0ab7a7fb9164d6987392b08a9ed7da5 schema:issueNumber 1
261 rdf:type schema:PublicationIssue
262 Nec665f292d374fcd99785ef71f153930 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
263 schema:name Retrospective Studies
264 rdf:type schema:DefinedTerm
265 Nf05a9cc59e75469ea8ede0db2e53ab8a schema:name pubmed_id
266 schema:value 20736934
267 rdf:type schema:PropertyValue
268 Nf2e0a40120d446aca7d82c83e82bb7f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
269 schema:name Treatment Outcome
270 rdf:type schema:DefinedTerm
271 Nffc74d6404854b49bcd1b231b7d726db rdf:first sg:person.01201614045.33
272 rdf:rest N615447ee4ed94018b8654629f9619a33
273 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
274 schema:name Medical and Health Sciences
275 rdf:type schema:DefinedTerm
276 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
277 schema:name Clinical Sciences
278 rdf:type schema:DefinedTerm
279 sg:journal.1019809 schema:issn 0002-9270
280 1572-0241
281 schema:name The American Journal of Gastroenterology
282 schema:publisher Wolters Kluwer
283 rdf:type schema:Periodical
284 sg:person.01017252245.99 schema:affiliation grid-institutes:grid.411599.1
285 schema:familyName Rebours
286 schema:givenName Vinciane
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017252245.99
288 rdf:type schema:Person
289 sg:person.01114775766.42 schema:affiliation grid-institutes:grid.411599.1
290 schema:familyName Le Baleur
291 schema:givenName Yann
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114775766.42
293 rdf:type schema:Person
294 sg:person.01201614045.33 schema:affiliation grid-institutes:grid.411599.1
295 schema:familyName Sauvanet
296 schema:givenName Alain
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201614045.33
298 rdf:type schema:Person
299 sg:person.01231224366.16 schema:affiliation grid-institutes:grid.411599.1
300 schema:familyName Vullierme
301 schema:givenName Marie Pierre
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231224366.16
303 rdf:type schema:Person
304 sg:person.01310130627.51 schema:affiliation grid-institutes:grid.411599.1
305 schema:familyName Voitot
306 schema:givenName Hélène
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310130627.51
308 rdf:type schema:Person
309 sg:person.01351504544.65 schema:affiliation grid-institutes:grid.411599.1
310 schema:familyName Maire
311 schema:givenName Frédérique
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351504544.65
313 rdf:type schema:Person
314 sg:person.01355345644.55 schema:affiliation grid-institutes:grid.411599.1
315 schema:familyName Hammel
316 schema:givenName Pascal
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355345644.55
318 rdf:type schema:Person
319 sg:person.0640551545.21 schema:affiliation grid-institutes:grid.411599.1
320 schema:familyName Ruszniewski
321 schema:givenName Philippe
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640551545.21
323 rdf:type schema:Person
324 sg:person.0736275266.26 schema:affiliation grid-institutes:grid.411599.1
325 schema:familyName Hentic
326 schema:givenName Olivia
327 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736275266.26
328 rdf:type schema:Person
329 sg:person.0740232450.15 schema:affiliation grid-institutes:grid.411599.1
330 schema:familyName Lévy
331 schema:givenName Philippe
332 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740232450.15
333 rdf:type schema:Person
334 sg:person.0751137045.27 schema:affiliation grid-institutes:grid.411599.1
335 schema:familyName Couvelard
336 schema:givenName Anne
337 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751137045.27
338 rdf:type schema:Person
339 sg:pub.10.1007/s00296-009-0843-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017767428
340 https://doi.org/10.1007/s00296-009-0843-5
341 rdf:type schema:CreativeWork
342 sg:pub.10.1007/s00535-002-1108-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075314630
343 https://doi.org/10.1007/s00535-002-1108-1
344 rdf:type schema:CreativeWork
345 sg:pub.10.1007/s00535-003-1178-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005542799
346 https://doi.org/10.1007/s00535-003-1178-8
347 rdf:type schema:CreativeWork
348 sg:pub.10.1038/ajg.2009.325 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006114762
349 https://doi.org/10.1038/ajg.2009.325
350 rdf:type schema:CreativeWork
351 sg:pub.10.1038/ajg.2009.327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039698368
352 https://doi.org/10.1038/ajg.2009.327
353 rdf:type schema:CreativeWork
354 sg:pub.10.1038/ajg.2009.336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036700394
355 https://doi.org/10.1038/ajg.2009.336
356 rdf:type schema:CreativeWork
357 sg:pub.10.1111/j.1572-0241.2005.00270.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017381662
358 https://doi.org/10.1111/j.1572-0241.2005.00270.x
359 rdf:type schema:CreativeWork
360 sg:pub.10.1111/j.1572-0241.2007.01531.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027749897
361 https://doi.org/10.1111/j.1572-0241.2007.01531.x
362 rdf:type schema:CreativeWork
363 sg:pub.10.1111/j.1572-0241.2008.01959_1.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010128041
364 https://doi.org/10.1111/j.1572-0241.2008.01959_1.x
365 rdf:type schema:CreativeWork
366 grid-institutes:grid.411599.1 schema:alternateName Department of Biology, Beaujon Hospital, Clichy, France
367 Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France
368 Department of Pathology, Beaujon Hospital, Clichy, France
369 Department of Radiology, Beaujon Hospital, Clichy, France
370 Department of Surgery, Beaujon Hospital, Clichy, France
371 schema:name Department of Biology, Beaujon Hospital, Clichy, France
372 Department of Gastroenterology and Pancreatology, Beaujon Hospital, AP-HP, Diderot-Paris VII University, Clichy, France
373 Department of Pathology, Beaujon Hospital, Clichy, France
374 Department of Radiology, Beaujon Hospital, Clichy, France
375 Department of Surgery, Beaujon Hospital, Clichy, France
376 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...